Sign In
Buy KHRNF
$0.00001
+0 (+0%)
At Close: Jul 31, 2026
Khiron Life Sciences Reveals 47% QoQ Spike In Medical Revenue, Q2 2021 Cannabis Revenue Increases 68% YoY
08:45am, Monday, 23'rd Aug 2021
Vertically integrated cannabis company Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQX:KHRNF) announced its latest financial results Monday, revealing a 68% year-over-year jump in revenue to CA$2.8 mill
Khiron Reports Q2 Results, 47% QoQ Increase in Medical Cannabis Revenues Driven by Colombia and Germany
07:00am, Monday, 23'rd Aug 2021
Q2 2021 revenues of $2.8 million, up 68% YoY Medical cannabis revenues reach $825,500, up 47% sequentially, with sales in Colombia, Germany, UK, and Peru contributing to gross medical cannabis profit
Khiron to Host Second Quarter 2021 Conference Call on August 23, 2021
07:30am, Tuesday, 17'th Aug 2021
TORONTO, Aug. 17, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core o
Khiron Publishes Inaugural 2020 ESG Report, Demonstrating Commitment to Sustainability and Continued Market Leadership
07:30am, Tuesday, 10'th Aug 2021
TORONTO, Aug. 10, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core o
Khiron Welcomes Dr. Eduardo Faveret as Medical Director for Brazil
08:30am, Thursday, 29'th Jul 2021
In 2013, Dr. Faveret became one of the first Brazilian physicians to prescribe medical cannabis, subsequently treating more than 3,000 patients with various conditions across the country As Medical Di
On July 23, 2021, the Colombian Government signed Decree 811 of 2021, expanding the regulatory framework for domestic and export medical cannabis markets in Colombia With the Decree, Colombia continue
Cannabis Co. Khiron: Shares Plunge On Heels Of $12.4M Offering Of Company's Units
10:31am, Tuesday, 06'th Jul 2021
Vertically integrated cannabis company Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQX: KHRNF) launched an overnight marketed offering on Monday of the company's units with a price of 45 cents per of
Khiron Announces Results of 2021 Annual General Meeting
04:30pm, Friday, 02'nd Jul 2021
Lytham Partners to Provide Investor Relations Services TORONTO, July 2, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN)(OTCQX: KHRNF)(Frankfurt: A2JMZC), a vert
Khiron successfully completes first medical cannabis sale in Brazil
08:30am, Friday, 02'nd Jul 2021
With over 200 million people, Brazil is Latin America´s largest addressable medical cannabis market, with the potential to reach USD$1.4 billion in annual revenue (Source: New Frontier Data) In partn
Watch Khiron Life Sciences & Jason Wild On The Benzinga Cannabis Hour
10:45pm, Thursday, 01'st Jul 2021
Benzinga's Cannabis Hour is a live daily show for cannabis investors. On Thursday's show, hosts Elliot Lane and Javier Hasse invited Alvaro Torres, CEO of Khiron Life Sciences (OTC: KHRNF), and
Vicente Fox, Khiron Board Member and Former President of Mexico, Applauds Mexican Supreme Court's Advancement of Cannabis Laws
09:26am, Wednesday, 30'th Jun 2021
Mexico's Supreme Court has voted to decriminalize adult use cannabis, allowing adults to apply for permits to cultivate and consume their own cannabis Khiron reiterates plans to enter Mexican medical
Khiron Accelerates Entry into Mexico, Awarded High-THC Extract Export Quotas for Mexico by the Government of Colombia
09:10am, Monday, 28'th Jun 2021
With a population close to 130 million people, Mexico is among the top 15 economies worldwide and second largest in Latin America. Approximately 11.7 million people have conditions treatable with medi
Khiron Life Sciences - On A Growth Trajectory
03:11pm, Friday, 25'th Jun 2021
Khiron has been the first company licensed in Colombia to cultivate, produce, and distribute high- and low-THC medical cannabis across the nation.
Khiron provides European management updates
05:36pm, Monday, 14'th Jun 2021
TORONTO, June 14, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core
Khiron Life Sciences Celebrates Big Growth in Colombia and Expands into New Latin American and European Markets
01:02pm, Thursday, 10'th Jun 2021
According to New Frontier Data , 12.8 million Colombians have conditions that could benefit from medical cannabis. Chronic pain is the leading medical condition, consistent with findings from Khiron L
